Answers are grounded in this paper and cite their sources.
OBJECTIVE: We evaluated whether placenta accreta spectrum (PAS) patients who delivered at accreta centers had reduced severe maternal morbidity (SMM), and we tested for the presence of racial disparity in SMM at these centers. METHODS: This is a mixed-methods, cross-sectional, population-based study of California hospitals with at least 200 annual delivery discharges from 2019 to 2021. Hospital discharge data from 2018 were used to assess the distribution of PAS cases in California hospitals and identify "high-volume" accreta hospitals (≥6 PAS cases). Hospitals meeting 7 predefined criteria by interview were labeled as accreta centers. Delivery discharges with PAS diagnostic codes from 2019 to 2021 were aggregated for these hospitals. Bivariate analyses were performed between patient risk factors and "performance" SMM (pSMM) (Yes/No). pSMM is a modified version of the Centers for Disease Control and Prevention SMM measure for hospital comparisons of potentially preventable SMM. We report rates of pSMM (defined without counting hysterectomy) by center status. A multiple hierarchical logistic regression model was constructed for the pSMM outcome. Observed-to-expected (O/E) ratios for pSMM were calculated to evaluate differences by race/ethnicity. No differences in aggregate O/E ratios by race/ethnicity were identified. CONCLUSIONS: PAS patients delivered at non-centers were twice as likely to experience pSMM, although this finding did not reach statistical significance. As rates of PAS increase, the development of standardized metrics to track improvement in clinical and patient-reported outcome measures appears warranted.
No takes yet. Share an insight, caveat, or question.
Gregory et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: